Researchers explored whether Mesenchymal stem cell- (MSC-) derived extracellular vesicles-delivered lipocalin-type prostaglandin D2 synthase (L-PGDS) could inhibit gastric cancer progression.
[Stem Cells International]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
171270
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
